Applying fluid biomarkers to Alzheimer's disease

Volume: 313, Issue: 1, Pages: C3 - C10
Published: Jul 1, 2017
Abstract
Alzheimer’s disease (AD) is a common neurodegenerative disease that starts with a clinically silent phase of a decade or more during which brain pathologies accumulate predominantly in the medial temporal lobe but also elsewhere in the brain. Network dysfunction and clinical symptoms typically appear when senile plaque (amyloid-β) and neurofibrillary tangle (tau) pathologies meet in the brain parenchyma, producing synapse and neuronal loss. For...
Paper Details
Title
Applying fluid biomarkers to Alzheimer's disease
Published Date
Jul 1, 2017
Volume
313
Issue
1
Pages
C3 - C10
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.